Dry Powder Inhalers (DPIs) are rapidly expanding in the respiratory therapeutics market, driven by increasing demand for high-precision pulmonary drug delivery. Scaling DPI production involves complex engineering decisions that balance sterility, consistency, productivity, and regulatory compliance. Modern systems from upstream processing to final filling must integrate automated controls, aseptic design, and advanced sterilization strategies. Companies like dde enterprises are helping biopharma manufacturers achieve these goals with optimized processing solutions for MDI / DPI and other sterile-formulations.

https://www.ddentp.com/smarter-solutions